[HTML][HTML] Neurodegenerative diseases–is metabolic deficiency the root cause?

VR Muddapu, SAP Dharshini… - Frontiers in …, 2020 - frontiersin.org
Neurodegenerative diseases, including Alzheimer, Parkinson, Huntington, and amyotrophic
lateral sclerosis, are a prominent class of neurological diseases currently without a cure …

[HTML][HTML] Molecular and cellular mechanisms affected in ALS

L Le Gall, E Anakor, O Connolly… - Journal of personalized …, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a terminal late-onset condition characterized by the
loss of upper and lower motor neurons. Mutations in more than 30 genes are associated to …

[HTML][HTML] Potential neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation

Q Yang, Q Huang, Z Hu, X Tang - Frontiers in neuroscience, 2019 - frontiersin.org
Stroke is a major cause of death and adult disability. However, therapeutic options remain
limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events …

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers

NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol… - Brain, 2014 - academic.oup.com
GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine
production in nigrostriatal cells. Loss-of-function mutations in GCH1 result in severe …

Dopamine D2 receptor availability is linked to hippocampal–caudate functional connectivity and episodic memory

L Nyberg, N Karalija, A Salami… - Proceedings of the …, 2016 - National Acad Sciences
D1 and D2 dopamine receptors (D1DRs and D2DRs) may contribute differently to various
aspects of memory and cognition. The D1DR system has been linked to functions supported …

Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma

Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang… - Cancer research, 2020 - AACR
Anti-VEGF therapy prolongs recurrence-free survival in patients with glioblastoma but does
not improve overall survival. To address this discrepancy, we investigated immunologic …

IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation

A Mortazavi, I Fayed, M Bachani, T Dowdy… - Neuro …, 2022 - academic.oup.com
Background Uncontrolled seizures in patients with gliomas have a significant impact on
quality of life and morbidity, yet the mechanisms through which these tumors cause seizures …

A model of the mitochondrial basis of bipolar disorder

G Morris, K Walder, SL McGee, OM Dean… - Neuroscience & …, 2017 - Elsevier
Background Bipolar disorder phenomenologically is a biphasic disorder of energy
availability; increased in mania and decreased in depression. In consort, there is …

The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases

G Morris, M Berk, P Galecki, K Walder, M Maes - Molecular neurobiology, 2016 - Springer
Many patients with systemic immune-inflammatory and neuro-inflammatory disorders,
including depression, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's disease …

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases

J Duarte-Neves, LP de Almeida, C Cavadas - Neurobiology of disease, 2016 - Elsevier
Abstract Neuropeptide Y (NPY) and NPY receptors are widely expressed in the mammalian
central nervous system. Studies in both humans and rodent models revealed that brain NPY …